GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	3.06B
Revenue (ttm)	3.27B
Net Income (ttm)	242.09M
Shares Out	83.51M
EPS (ttm)	2.90
PE Ratio	12.65
Forward PE	n/a
Dividend	0.75 (2.02%)
Ex-Dividend Date	Jul 18, 2024

Volume	4,848
Average Volume	85,343
Open	36.68
Previous Close	36.68
Day's Range	36.00 - 36.98
52-Week Range	24.70 - 47.30
Beta	0.93
RSI	37.85
Earnings Date	Aug 14, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.